Blepharospasm
📧 Sign up to get email alerts when something new happens for Blepharospasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: DaxibotulinumtoxinA for Blepharospasm [Phase 2]
Phase 2 trial update for daxibotulinumtoxinA in blepharospasm notes the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia [NA]
A clinical trial analyzed gait changes in patients with focal dystonia before and after botulinum toxin treatment. The study has completed a…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm [Phase 2]
A Phase 2 exploratory study of dipraglurant (ADX48621) for blepharospasm and dystonia has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure [Phase 4]
A Phase 4 trial evaluating a topical botulinum toxin eyedrop for excessive tearing and eyelid spasm was terminated, with results posted on 2…
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: Wumeiwan Jiawei Fang Use in Patients With Blepharospasm [Phase 2, Phase 3]
Clinical trial update for Wumeiwan Jiawei Fang in blepharospasm indicates ongoing Phase 2/Phase 3 exploration for related conditions, with n…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm [Phase 2, Phase 3]
A Phase 2/3 trial evaluating non-psychoactive cannabidiol as an adjunct to botulinum toxin for blepharospasm has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm [Phase 2]
Phase 2 study evaluating a single administration of 3 doses of Dysport for benign essential blepharospasm has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm [Phase 2, Phase 3]
A clinical trial update reports safety and efficacy data for NABOTA in the treatment of essential blepharospasm across Phase 2 and Phase 3 s…
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm [Phase 4]
Phase 4 clinical trial comparing pretarsal vs preseptal botulinum toxin for eyelid spasm has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-01Clinical Trial Update: Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid [Phase 3]
A Phase 3 study evaluated botulinum toxin type A versus placebo for bilateral blepharospasm. The trial assessed efficacy and safety, and res…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: A Mechanical Device for Blepharospasm [NA]
This clinical trial update reports the completion of a study evaluating a mechanical device for blepharospasm.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Brain Stimulation to Treat Blepharospasm or Meige Syndrome [Phase 2]
A Phase 2 trial evaluating brain stimulation to treat blepharospasm and Meige syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Brain Changes in Blepharospasm
This entry reports a completed clinical trial sponsored by NINDS investigating brain changes in patients with blepharospasm.
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: Acetyl Hexapeptide-8 for Blepharospasm [Phase 2]
Phase 2 clinical trial update for Acetyl Hexapeptide-8 in blepharospasm (focal dystonia) shows terminated status with results posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Eyelid Movement Sensor Device- Blinking Characterizing [NA]
The completed trial evaluated an eyelid movement sensor device for characterizing blinking in eyelid movement disorders.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
A United States clinical trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm has completed, sponsored by Me…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: MDs on Botox Utility (MOBILITY)
A completed clinical trial evaluating Botox (onabotulinumtoxinA) for multiple movement disorders including blepharospasm, cervical dystonia …
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Acetyl Hexapeptide-8 (AH8) for blepharospasm, a form of focal dystonia, has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Blepharospasm Short Interval [Phase 2]
A Phase 2 trial for blepharospasm sponsored by Merz Pharmaceuticals was terminated.
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm [Phase 3]
Phase 3 trial comparing incobotulinumtoxinA (Xeomin) to placebo in blepharospasm; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2009-07-09Clinical Trial Update: Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm [Phase 4]
This Phase 4 clinical trial compares two botulinum toxin type A products for the treatment of blepharospasm; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm [Phase 3]
A Phase 3 trial comparing a Korean botulinum toxin type A formulation to Botox for essential blepharospasm has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Mexiletine for the Treatment of Focal Dystonia [Phase 2]
A Phase 2 trial evaluating mexiletine for focal dystonia, including blepharospasm, has completed. The update summarizes the trial's efficacy…